🇨🇦 Ropivacaine 0,375% in SFICB block in Canada

Ropivacaine 0,375% in SFICB block (Ropivacaine 0,375% in SFICB block) regulatory status in Canada.

Marketing authorisation

Ropivacaine 0,375% in SFICB block in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ropivacaine 0,375% in SFICB block approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Ropivacaine 0,375% in SFICB block in Canada?

University of Liege is the originator. The local marketing authorisation holder may differ — check the official source linked above.